Sysmex had 39 patents in future of work during Q2 2024. The patents filed by Sysmex Corp in Q2 2024 include a method for determining poor blood collection by analyzing coagulation waveform data, an oil removal method for oil immersion object lenses on smear surfaces, and specimen measurement apparatuses with features such as specimen transport units and rack setting parts for efficient specimen handling and measurement. GlobalData’s report on Sysmex gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Sysmex had no grants in future of work as a theme in Q2 2024.
Recent Patents
Application: Poor blood collection determination method, blood coagulation analysis method, and blood coagulation analysis system (Patent ID: US20240210425A1)
The patent filed by Sysmex Corp. describes a method for determining poor blood collection by mixing a blood specimen with a coagulation measurement reagent to prepare a sample, obtaining measurement values representing the degree of coagulation, analyzing coagulation waveform data based on these values, and making a determination regarding the quality of blood collection. The method involves assessing various parameters related to the coagulation process, such as coagulation rate and time, using mathematical models and differential waveform analysis to identify poor blood collection accurately.
Furthermore, the patent outlines the use of deep learning algorithms for determination, the specific reagents involved in the process, and the presentation of results indicating poor blood collection. Additionally, the patent extends to a blood coagulation analysis method that includes obtaining an analytic value related to the blood specimen's coagulability and a computer-based method for determining poor blood collection based on received coagulation waveform data. The patent also introduces a blood coagulation analysis system comprising a sample preparation unit, a detector for measurement values, and a controller for generating coagulation waveform data and performing determinations based on this data, providing a comprehensive approach to assessing blood collection quality.
To know more about GlobalData’s detailed insights on Sysmex, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.